When did antipsychotics for nausea become a thing? A long time ago. Haloperidol and other anti-dopaminergic agents like metaclopromide have a long history of use both in the hospice, palliative care, and oncology setting. Now we have a little more evidence that at least one of these drugs, olanzapine, may help with the prevention of chemotherapy induced nausea and vomiting.

Not shocking for those who have been doing this work for a while – adding an anti-dopenergic agent works. The proportion of patients with no chemotherapy-induced nausea was significantly greater with olanzapine than with placebo for multiple time points:

0 to 24 hours after chemotherapy: 74% vs. 45%

25 to 120 hours after chemotherapy: 42% vs. 25%

Overall 120-hour period: 37% vs. 22%

The complete-response rate was also significantly increased with olanzapine compared to placebo during the three periods:

0 to 24 hours after chemotherapy: 86% versus 65%

25 to 120 hours after chemotherapy: 67% versus 52%

Overall 120-hour period: 64% versus 41%

The biggest adverse effect was sedation which was severe in 5% of patients at day 2, but nobody stopped the study because of sedation.

Take Home Point

While this is a study of a particular antipsychotic, olanzapine, one does have to wonder if there would have been similar findings if they used a tried and true hospice medication: haloperidol. Nevertheless, it does serve as an important study addressing one of the most common symptoms we see in palliative care.

1 comment:

Whatever disease we suffer, we should be courageous to face it. Being bold will help us to get rid of the disease soon. This article has mentioned everything very correctly. It's very sad thinking about the chemotherapy.

Total Pageviews

Welcome to GeriPal

GeriPal (Geriatrics and Palliative care) is a forum for discourse, recent news and research, and freethinking commentary. Our objectives are: 1) to create an online community of interdisciplinary providers interested in geriatrics or palliative care; 2) to provide an open forum for the exchange of ideas and disruptive commentary that changes clinical practice and health care policy; and 3) to change the world.

No confidential patient information should be placed on GeriPal, nor should any confidential information be placed in the comments. The information provided on GeriPal is designed to complement, not replace, the relationship between a patient and and his/her own medical providers. The editors (Alex Smith and Eric Widera) reserve the right to remove comments that are deemed inappropriate due to the commercial, abusive, or offensive nature of a comment. If you think your comment was deleted for inappropriate reasons, please email either Alex or Eric.

GeriPal's mission is to improve the disemination of information in both geriatics and palliative medicine. GeriPal was created with the support of the Division of Geriatrics at the University of California San Francisco. Its content though is strictly the work of its authors and has no affiliation with or support from any organization or institution. All opinions expressed on this website are solely those of its authors & do not reflect the opinions of any academic institution or medical center. This web site does not accept advertisements. All email addresses collected by GeriPal for feed distribution will be kept confidential and will never be used for commercial reasons. If you reproduce the material on the website please cite appropriately. For questions regarding the site please email Alex Smith, MD (aksmith@ucsf.edu) or Eric Widera, MD (eric.widera@ucsf.edu)